ED-Finanzas

No es posible guardar favoritos sin iniciar sesión.

Usá Login / Registrar en el header (usuario + contraseña).

KPTI

Karyopharm Therapeutics Inc · NASD

Healthcare · Biotechnology · USA · Nano

1.81
-0.21 (-10.40%)
Aug 17 3:59 PM ET

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A. Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008 and is headquartered in Newton, MA.

Chart

Lightweight Charts · Yahoo Finance

Date Headline URL From
Aug-14-26 08:30AM Karyopharm Therapeutics Inc. Q2 2026 Earnings Call Summary link (Moby)
Aug-13-26 07:09PM Karyopharm Therapeutics Inc (KPTI) (Q2 2026) Earnings Call Highlights: SENTRY Trial Success and ... link (GuruFocus.com)
Aug-13-26 07:48AM Karyopharm Therapeutics: Q2 Earnings Snapshot link (Associated Press)
Aug-13-26 07:30AM Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission link (PR Newswire)
Aug-10-26 07:30AM Karyopharm to Report Second Quarter 2026 Financial Results on August 13, 2026 link (PR Newswire)
Aug-03-26 04:05PM Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Jul-31-26 07:02AM Karyopharms XPORT-EC-042 study fails to meet primary endpoint link (Clinical Trials Arena)
Jul-30-26 06:27PM Why Is KPTI Stock Down 69% After-Hours Today? link (Stocktwits)
Jul-30-26 04:06PM Karyopharm Plans to Submit sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis Under Accelerated Approval Pathway link (PR Newswire)
Jul-30-26 04:05PM Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer link (PR Newswire)
Jul-01-26 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Jun-03-26 04:15PM Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 link (PR Newswire)
Jun-02-26 10:02AM Karyopharm's Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis Selected for Late-Breaking Oral Presentation at EHA 2026 link (PR Newswire)
Jun-02-26 08:59AM Karyopharm to Present Results from Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis in Late-Breaking Oral Presentation at ASCO 2026 with Simultaneous Publication in the Journal of Clinical Oncology link (PR Newswire)
Jun-01-26 04:05PM Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Jun-01-26 07:30AM Karyopharm to Host Investor Conference Call Featuring Expert Perspectives on the Phase 3 SENTRY Trial in Myelofibrosis Following 2026 ASCO Presentation link (PR Newswire)
May-28-26 11:29AM Wall Street Analysts Think Karyopharm Therapeutics (KPTI) Could Surge 70.46%: Read This Before Placing a Bet link (Quartz)
May-28-26 07:30AM Karyopharm to Participate at the 2026 Jefferies Global Healthcare Conference link (PR Newswire)
May-14-26 07:04PM Karyopharm Therapeutics Inc (KPTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... link (GuruFocus.com)
May-14-26 05:19PM Karyopharm Therapeutics Inc. Q1 2026 Earnings Call Summary link (Moby)
May-14-26 07:40AM Karyopharm Therapeutics: Q1 Earnings Snapshot link (Associated Press)
May-14-26 07:30AM Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment link (PR Newswire)
May-12-26 07:30AM Karyopharm to Participate at Upcoming Investor Conferences link (PR Newswire)
May-07-26 07:30AM Karyopharm to Report First Quarter 2026 Financial Results on May 14, 2026 link (PR Newswire)
Apr-21-26 10:32AM Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Selected for Late-Breaking Oral Presentation at ASCO 2026 Annual Meeting link (PR Newswire)
Mar-31-26 08:07PM Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar? link (Quartz)
Mar-24-26 07:01AM Karyopharm Announces $30 Million Private Placement with RA Capital link (PR Newswire)
Mar-24-26 07:00AM Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction link (PR Newswire)
Mar-24-26 05:47AM Karyopharm myeloma drug yields mixed data in myelofibrosis trial link (BioPharma Dive)
Mar-02-26 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Feb-23-26 09:09PM Karyopharm Therapeutics Shareholders Approve Plan to Nearly Double Authorized Shares at Special Meeting link (MarketBeat)
Feb-18-26 09:55AM Wall Street Analysts Believe Karyopharm Therapeutics (KPTI) Could Rally 56.06%: Here's is How to Trade link (Zacks)
Feb-12-26 02:01PM Karyopharm Therapeutics Inc (KPTI) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst ... link (GuruFocus.com)
Feb-12-26 01:02PM Karyopharm Therapeutics Q4 Earnings Call Highlights link (MarketBeat)
Feb-12-26 12:33PM Karyopharm Therapeutics Inc. Q4 2025 Earnings Call Summary link (Moby)
Feb-12-26 08:45AM Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates link (Zacks)
Feb-12-26 07:47AM Karyopharm Therapeutics: Q4 Earnings Snapshot link (Associated Press Finance)
Feb-12-26 07:30AM Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress link (PR Newswire)
Feb-05-26 07:30AM Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 link (PR Newswire)
Feb-02-26 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Jan-12-26 07:00AM Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026 link (PR Newswire)
Jan-02-26 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Dec-08-25 07:00AM Karyopharm to Participate in Baird's Biotech Discovery Series link (PR Newswire)
Dec-01-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Dec-01-25 07:00AM Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference link (PR Newswire)
Nov-07-25 08:01PM Karyopharm Therapeutics Inc (KPTI) Q3 2025 Earnings Call Highlights: Strategic Advances and ... link (GuruFocus.com)
Nov-03-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Nov-03-25 07:06AM Karyopharm Therapeutics: Q3 Earnings Snapshot link (Associated Press Finance)
Nov-03-25 07:00AM Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress link (PR Newswire)
Oct-31-25 09:35AM Earnings To Watch: Karyopharm Therapeutics Inc (KPTI) Reports Q3 2025 Result link (GuruFocus.com)
Oct-28-25 10:00AM OmniAb, Inc. (OABI) Expected to Beat Earnings Estimates: Should You Buy? link (Zacks)
Oct-27-25 07:00AM Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025 link (PR Newswire)
Oct-17-25 09:55AM Karyopharm Therapeutics (KPTI)'s Technical Outlook is Bright After Key Golden Cross link (Zacks)
Oct-08-25 07:00AM Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis link (PR Newswire)
Oct-01-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Sep-24-25 03:48AM Karyopharm Therapeutics (KPTI) Moves 27.9% Higher: Will This Strength Last? link (Zacks)
Sep-11-25 07:40AM Karyopharm concludes enrolment in Phase III myelofibrosis treatment trial link (Clinical Trials Arena)
Sep-10-25 07:00AM Karyopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis link (PR Newswire)
Sep-02-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Aug-12-25 03:03AM Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Call Highlights: Navigating Financial ... link (GuruFocus.com)
Aug-11-25 07:00PM Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Lags Revenue Estimates link (Zacks)
Aug-11-25 05:57PM Karyopharm Therapeutics: Q2 Earnings Snapshot link (Associated Press Finance)
Aug-11-25 07:30AM Karyopharm Reports Second Quarter 2025 Financial Results and Highlights Recent Company Progress link (PR Newswire)
Aug-08-25 09:33AM Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Report Preview: What To Expect link (GuruFocus.com)
Aug-07-25 08:50AM Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Surpass Estimates link (Zacks)
Aug-05-25 07:00AM Karyopharm to Report Second Quarter 2025 Financial Results on August 11, 2025 link (PR Newswire)
Aug-01-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Jul-30-25 07:35AM United Therapeutics (UTHR) Misses Q2 Earnings Estimates link (Zacks)
Jul-29-25 10:00AM Karyopharm Therapeutics (KPTI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release link (Zacks)
Jul-01-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Jun-03-25 08:00AM Karyopharm to Present at the Jefferies Global Healthcare Conference link (PR Newswire)
Jun-02-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
May-26-25 09:55AM Here's Why Karyopharm Therapeutics (KPTI) Is a Great 'Buy the Bottom' Stock Now link (Zacks)
May-19-25 09:55AM Does Karyopharm Therapeutics (KPTI) Have the Potential to Rally 521.62% as Wall Street Analysts Expect? link (Zacks)
May-19-25 07:00AM Karyopharm to Participate at the 2025 RBC Capital Markets Global Healthcare Conference link (PR Newswire)
May-14-25 09:31AM Karyopharm Announces Poster Presentation on Selinexor in Myelofibrosis at the 2025 European Hematology Association Annual Meeting link (PR Newswire)
May-13-25 03:08AM Karyopharm Therapeutics Inc (KPTI) Q1 2025 Earnings Call Highlights: Promising Clinical ... link (GuruFocus.com)
May-12-25 05:25PM Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Lags Revenue Estimates link (Zacks)
May-12-25 04:26PM Karyopharm Therapeutics: Q1 Earnings Snapshot link (Associated Press Finance)
May-12-25 04:05PM Karyopharm Reports First Quarter 2025 Financial Results and Announces New Data in Myelofibrosis that Further Suggests Selinexor May Lead to Meaningful Spleen Volume Reduction, Symptom Improvement, Hemoglobin Stabilization and Disease Modification link (PR Newswire)
May-08-25 04:05PM Karyopharm to Report First Quarter 2025 Financial Results on May 12, 2025 link (PR Newswire)
May-05-25 05:10PM Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates link (Zacks)
May-01-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Apr-01-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Apr-01-25 11:50AM Biotech stocks slide as Marks resignation seen being negative for sector link (TipRanks)
Mar-03-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Feb-24-25 08:40AM Karyopharm Announces 1-for-15 Reverse Stock Split link (PR Newswire)
Feb-20-25 02:03AM Karyopharm Therapeutics Inc (KPTI) Q4 2024 Earnings Call Highlights: Navigating Revenue ... link (GuruFocus.com)
Feb-20-25 01:39AM Q4 2024 Karyopharm Therapeutics Inc Earnings Call link (Thomson Reuters StreetEvents)
Feb-19-25 11:45AM Karyopharm Therapeutics (KPTI) Q4 2024 Earnings Call Transcript link (Motley Fool)
Feb-19-25 08:40AM Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates link (Zacks)
Feb-19-25 07:45AM Karyopharm Therapeutics: Q4 Earnings Snapshot link (Associated Press Finance)
Feb-19-25 07:30AM Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress link (PR Newswire)
Feb-19-25 04:59AM Karyopharm Therapeutics Inc (KPTI) Q4 2024 Earnings Report Preview: What To Look For link (GuruFocus.com)
Feb-12-25 07:00AM Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 link (PR Newswire)
Feb-03-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Jan-13-25 08:30AM Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives link (PR Newswire)
Jan-07-25 09:28AM Why Karyopharm Therapeutics (KPTI) Is Among the Best Penny Stocks to Invest In According to Media? link (Insider Monkey)
Jan-02-25 04:05PM Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) link (PR Newswire)
Jan-02-25 07:00AM Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer link (PR Newswire)